Skip to content
healthcare.dev

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

NDC 0363-0094, Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, tablet, film coated, extended release, from WALGREEN CO..

Product NDC
0363-0094
Status
Listed
Labeler
WALGREEN CO.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209116
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0094 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEXOFENADINE HYDROCHLORIDE60 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0363-0094-67003630094672 BLISTER PACK in 1 CARTON (0363-0094-67) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
0363-0094-84003630094843 BLISTER PACK in 1 CARTON (0363-0094-84) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0363-0094 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0094 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0363-0094. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.